Related Experiment Video
Updated: Nov 15, 2025

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene
Published on: April 1, 2019
The role of ADRB2 gene polymorphisms in malignancies
Yaqian Wang1, Shujuan Jiang2,3,4
1Department of Respiratory and Critical Care Medicine, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jingwu Road 324#, Jinan, 250021, Shandong, China.
Abstract:
Beta-2-adrenergic receptor is a member of the G protein-coupled receptor superfamily, which is highly expressed in most malignancies. There is increasing evidence showing that beta-2-adrenergic receptors are associated with carcinogenesis, proliferation, immune regulation, invasion, angiogenesis, clinical prognosis and treatment resistance in malignancies. Polymorphisms of the ADRB2 gene have been confirmed to be associated with transcriptional activity, mRNA translation, and beta-2-adrenergic receptor expression and sensitivity. This review discusses clinically relevant examples of single nucleotide polymorphisms of ADRB2 in malignancies and the effects of these polymorphisms on cancer susceptibility, prognosis and treatment response of cancer patients.
Insights
Genetic variations in the beta-2 adrenergic receptor (ADRB2) gene influence cancer development and progression. This review explores ADRB2 polymorphisms and their impact on cancer susceptibility, prognosis, and treatment outcomes.
Area of Science:
- Oncology
- Pharmacogenomics
- Molecular Biology
Background:
- The beta-2 adrenergic receptor (ADRB2) is a G protein-coupled receptor implicated in various cancers.
- ADRB2 signaling is linked to key cancer hallmarks including proliferation, invasion, and angiogenesis.
- Expression and function of ADRB2 are modulated by genetic variations within the ADRB2 gene.
Purpose of the Study:
- To review the clinical significance of ADRB2 gene polymorphisms in malignancies.
- To elucidate the impact of these polymorphisms on cancer susceptibility, prognosis, and therapeutic response.
Main Methods:
- Literature review of studies investigating ADRB2 polymorphisms in various cancer types.
- Analysis of the association between specific ADRB2 single nucleotide polymorphisms (SNPs) and clinical outcomes.
- Examination of the functional consequences of ADRB2 polymorphisms on receptor expression and sensitivity.
Main Results:
- Certain ADRB2 polymorphisms are associated with altered cancer risk and patient prognosis.
- These genetic variations can influence treatment efficacy and resistance in cancer patients.
- Functional studies demonstrate that ADRB2 SNPs affect receptor expression, signaling, and cellular processes relevant to cancer.
Conclusions:
- ADRB2 gene polymorphisms represent a significant factor in cancer development and progression.
- Understanding these pharmacogenetic variations can aid in personalized cancer risk assessment and treatment strategies.
- Targeting ADRB2 signaling pathways, considering genetic background, may offer novel therapeutic opportunities in oncology.
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Ras Gene
Ras is a...
Abnormal Proliferation
RNA Editing
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...

